LIMITED-STAGE SMALL CELL LUNG CANCER
Clinical trials for LIMITED-STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED-STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED-STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lung cancer patients: drug combo may extend survival
Disease control OngoingThis study tests whether adding the drug serplulimab to standard chemotherapy and radiation helps people with limited-stage small cell lung cancer live longer without their cancer growing. About 511 adults with this type of lung cancer will take part. The goal is to see if the ne…
Matched conditions: LIMITED-STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 26, 2026 04:52 UTC
-
New hope for lung cancer patients: drug aims to stop cancer's return
Disease control OngoingThis study tests a drug called tarlatamab in people with limited-stage small cell lung cancer whose cancer has not grown after standard chemotherapy and radiation. About 404 participants will receive either tarlatamab or a placebo to see if the drug can delay cancer progression a…
Matched conditions: LIMITED-STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 22, 2026 13:55 UTC